https://www.avient.com/news/mecall-srl-replaces-lead-trilliant-radiation-shielding-polyone
PolyOne Trilliant injection moldable solutions block radiation as effectively as lead, providing medical device manufacturers with an easy-to-manufacture and more sustainable alternative,” said Holger Kronimus, vice president, Europe and general manager, Engineered Materials Europe, PolyOne Corporation.
https://www.avient.com/news/cosmetic-packaging-reimagined-versaflex-pkg-thermoplastic-elastomers-polyone
These REACH SVHC compliant TPEs have been particularly successful in Europe, where PolyOne application engineers are collaborating with brands in the early product development stages to help create highly effective, differentiated products.”
https://www.avient.com/news/avient-introduces-versaflex-tf-adhesive-tpes-textile-fabrics
This new TPE technology can provide a cost-effective alternative to TPU adhesive films and traditional glue.
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2023-results
Changes in assets and liabilities, net of the effect of acquisitions:
Effect of exchange rate changes on cash
In addition, operating income before the effect of special items is a component of
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2023-results
Changes in assets and liabilities, net of the effect of acquisitions:
Effect of exchange rate changes on cash
In addition, operating income before the effect of special items is a component of
https://www.avient.com/investor-center/news/avient-provides-fourth-quarter-2020-updates
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to continue to pay cash dividends including at the increased rate; the amount and timing of share repurchases, if any; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.
performance in prior periods without the effect of items that, by their nature, tend to obscure
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures, including adjustments related to contingent consideration; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non- recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results.
https://www.avient.com/products/polymer-additives/surface-modifier-additives/oncap-anti-fogging-additives
OnCap™ Anti-Fogging Additives are a cost-effective means of preventing water droplets from forming inside food packaging.
https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/remafin-ep-white-colorants
High loading and optimized dispersion of pigments provide a cost-effective way to meet light transmission requirements while fully supporting regulatory compliance for packaging materials.
https://www.avient.com/careers/career-opportunities
Participants learn how to lead others more effectively to help their teams consistently achieve business results.
https://www.avient.com/investor-center/news/polyone-appoints-giuseppe-di-salvo-vice-president-investor-relations-justin-m-hess-vice-president-corporate-controller
NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced two internal appointments effective